Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Burns

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a reviewR S Burns
Clinical Toxicology|January 1, 1976
Editorial. Phencyclidine: an emerging drug problemR S Burns, S E Lerner
NIDA Research Monograph|August 1, 1978
Phencyclidine use among youth: history, epidemiology, and acute and chronic intoxicationS E Lerner, R S Burns
Clinical Toxicology|January 1, 1976
Perspectives: acute phencyclidine intoxicationR S Burns, S E Lerner
JACEP|April 1, 1978
Phencyclidine deathsR S Burns, S E Lerner
NIDA Research Monograph|January 1, 1986
Legal issues associated with PCP abuse--the role of the forensic expertS E Lerner, R S Burns
Clinical Toxicology|January 1, 1978
Causes of phencyclidine-related deathsR S Burns, S E Lerner
Clinical Neuropharmacology|August 1, 1995
Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegilineT L Davis, M Roznoski, R S Burns
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegilineT L Davis, M Roznoski, R S Burns
Southern Medical Journal|October 1, 1995
Clonazepam-sensitive intermittent dystonic tremorT L Davis, P D Charles, R S Burns
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a reviewR S Burns
Clinical Toxicology|January 1, 1976
Editorial. Phencyclidine: an emerging drug problemR S Burns, S E Lerner
NIDA Research Monograph|August 1, 1978
Phencyclidine use among youth: history, epidemiology, and acute and chronic intoxicationS E Lerner, R S Burns
Clinical Toxicology|January 1, 1976
Perspectives: acute phencyclidine intoxicationR S Burns, S E Lerner
JACEP|April 1, 1978
Phencyclidine deathsR S Burns, S E Lerner
NIDA Research Monograph|January 1, 1986
Legal issues associated with PCP abuse--the role of the forensic expertS E Lerner, R S Burns
Clinical Toxicology|January 1, 1978
Causes of phencyclidine-related deathsR S Burns, S E Lerner
Clinical Neuropharmacology|August 1, 1995
Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegilineT L Davis, M Roznoski, R S Burns
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegilineT L Davis, M Roznoski, R S Burns
Southern Medical Journal|October 1, 1995
Clonazepam-sensitive intermittent dystonic tremorT L Davis, P D Charles, R S Burns
Pageof 7